Found: 83
Select item for more details and to access through your institution.
Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 2, p. 135, doi. 10.1007/s10637-006-5934-5
- By:
- Publication type:
- Article
ORIGINAL ARTICLES Sequential High-Dose Alkylating Therapy and Stem Cell Support for High-Risk Stage III Breast Cancer.
- Published in:
- Breast Journal, 2003, v. 9, n. 6, p. 472, doi. 10.1046/j.1524-4741.2003.09604.x
- By:
- Publication type:
- Article
Use of paclitaxel in patients with pre-existing cardiomyopathy: A review of our experience.
- Published in:
- International Journal of Cancer, 2001, v. 93, n. 1, p. 139, doi. 10.1002/ijc.1295
- By:
- Publication type:
- Article
Clinical Use of Monoclonal Antibodies to the Epidermal Growth Factor Receptor in Colorectal Cancer.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 8, p. 964
- By:
- Publication type:
- Article
Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural Networks.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-32441-y
- By:
- Publication type:
- Article
Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update.
- Published in:
- Drugs, 2023, v. 83, n. 3, p. 217, doi. 10.1007/s40265-023-01835-2
- By:
- Publication type:
- Article
NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01877-7
- By:
- Publication type:
- Article
Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy.
- Published in:
- Biologics: Targets & Therapy, 2009, v. 3, p. 419
- By:
- Publication type:
- Article
Docetaxel and Irinotecan Combination Chemotherapy in Advanced Esophageal Cancer.
- Published in:
- European Journal of Clinical & Medical Oncology, 2011, v. 3, n. 1, p. 1
- By:
- Publication type:
- Article
Docetaxel and Irinotecan Combination Chemotherapy in Advanced Esophageal Cancer.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma.
- Published in:
- Laryngoscope, 2012, v. 122, n. 12, p. 2762, doi. 10.1002/lary.23647
- By:
- Publication type:
- Article
Dose escalation and pharmacokinetic study of irinotecan in combination with paclitaxel in patients with advanced cancer.
- Published in:
- 2000
- By:
- Publication type:
- journal article
The room where it happens: addressing diversity, equity, and inclusion in National Clinical Trials Network clinical trial leadership.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 10, p. 1132, doi. 10.1093/jnci/djad121
- By:
- Publication type:
- Article
Clinical Trial Development in TP53-Mutated Locally Advanced and Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2022, v. 114, n. 12, p. 1619, doi. 10.1093/jnci/djac163
- By:
- Publication type:
- Article
The Quest to Eradicate HPV-Related Oropharyngeal Carcinoma: An Opportunity Not to Miss.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Hypoxia-Guided Therapy for Human Papillomavirus-Associated Oropharynx Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Response.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Hypofractionated Radiotherapy for Patients with Early-Stage Glottic Cancer: Patterns of Care and Survival.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Oncology and hematology.
- Published in:
- JAMA: Journal of the American Medical Association, 1995, v. 273, n. 21, p. 1702, doi. 10.1001/jama.1995.03520450072037
- By:
- Publication type:
- Article
Impact of <sup>18</sup>F-FDG PET Intensity Normalization on Radiomic Features of Oropharyngeal Squamous Cell Carcinomas and Machine Learning-Generated Biomarkers.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266637
- By:
- Publication type:
- Article
Impact of <sup>18</sup>F-FDG PET Intensity Normalization on Radiomic Features of Oropharyngeal Squamous Cell Carcinomas and Machine Learning-Generated Biomarkers.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 5, p. 803, doi. 10.2967/jnumed.123.266637
- By:
- Publication type:
- Article
Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial.
- Published in:
- Oncologist, 2023, v. 28, n. 9, p. 827, doi. 10.1093/oncolo/oyad096
- By:
- Publication type:
- Article
National treatment patterns in patients presenting with Stage IVC head and neck cancer: analysis of the National Cancer Database.
- Published in:
- Cancer Medicine, 2015, v. 4, n. 12, p. 1828, doi. 10.1002/cam4.546
- By:
- Publication type:
- Article
STING enhances cell death through regulation of reactive oxygen species and DNA damage.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22572-8
- By:
- Publication type:
- Article
Markers of Epithelial to Mesenchymal Transition in Association with Survival in Head and Neck Squamous Cell Carcinoma (HNSCC).
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0094273
- By:
- Publication type:
- Article
Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial
- Published in:
- Trials, 2014, v. 15, n. 1, p. 2, doi. 10.1186/1745-6215-15-469
- By:
- Publication type:
- Article
Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Top advances of the year: Head and neck cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 9, p. 1308, doi. 10.1002/cncr.34654
- By:
- Publication type:
- Article
Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 18, p. 3361, doi. 10.1002/cncr.33641
- By:
- Publication type:
- Article
Predictive classifier for intensive treatment of head and neck cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pathologic staging changes in oral cavity squamous cell carcinoma: Stage migration and implications for adjuvant treatment.
- Published in:
- Cancer (0008543X), 2019, v. 125, n. 17, p. 2975, doi. 10.1002/cncr.32161
- By:
- Publication type:
- Article
Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pathologic staging changes in oral cavity squamous cell carcinoma: Stage migration and implications for adjuvant treatment.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Five-Year Update of an Expanded Phase II Study of Dose-Dense and -Intense Doxorubicin, Paclitaxel and Cyclophosphamide (ATC) in High-Risk Breast Cancer.
- Published in:
- Oncology, 2005, v. 69, n. 5, p. 372, doi. 10.1159/000089991
- By:
- Publication type:
- Article
Predicting survival in head and neck squamous cell carcinoma from TP53 mutation.
- Published in:
- Human Genetics, 2015, v. 134, n. 5, p. 497, doi. 10.1007/s00439-014-1470-0
- By:
- Publication type:
- Article
The tumor genome in human immunodeficiency virus-related head and neck cancer: Exploitable targets?
- Published in:
- 2018
- By:
- Publication type:
- editorial
Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).
- Published in:
- 2017
- By:
- Publication type:
- journal article
The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.
- Published in:
- Cancer (0008543X), 2017, v. 123, n. 7, p. 1259, doi. 10.1002/cncr.30449
- By:
- Publication type:
- Article
Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Proposing prognostic thresholds for lymph node yield in clinically lymph node-negative and lymph node-positive cancers of the oral cavity.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Trends and variations in the use of adjuvant therapy for patients with head and neck cancer.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 21, p. 3353, doi. 10.1002/cncr.28870
- By:
- Publication type:
- Article
Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 6, p. 840, doi. 10.1002/cncr.28482
- By:
- Publication type:
- Article
A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303).
- Published in:
- 2011
- By:
- Publication type:
- journal article
A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 15, p. 3374, doi. 10.1002/cncr.25852
- By:
- Publication type:
- Article
A preclinical xenotransplantation animal model to assess human hematopoietic stem cell engraftment.
- Published in:
- Transfusion, 2004, v. 44, n. 4, p. 555, doi. 10.1111/j.1537-2995.2004.03285.x
- By:
- Publication type:
- Article
Comment on "Epidermal Growth Factor Receptor Is Essential for Toll-Like Receptor 3 Signaling".
- Published in:
- Science Signaling, 2012, v. 5, n. 254, p. 1, doi. 10.1126/scisignal.2003734
- By:
- Publication type:
- Article